The Nervous System and Metabolic Dysregulation: Emerging Evidence Converges on Ketogenic Diet Therapy
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
A link between metabolism and brain function is clear. Since ancient times, epileptic seizures were noted as treatable with fasting, and historical observations of the therapeutic benefits of fasting on epilepsy were confirmed nearly 100 years ago. Shortly thereafter a high fat, low-carbohydrate ketogenic diet (KD) debuted as a therapy to reduce seizures. This strict regimen could mimic the metabolic effects of fasting while allowing adequate caloric intake for ongoing energy demands. Today, KD therapy, which forces predominantly ketone-based rather than glucose-based metabolism, is now well-established as highly successful in reducing seizures. Cellular metabolic dysfunction in the nervous system has been recognized as existing side-by-side with nervous system disorders - although often with much less obvious cause-and-effect as the relationship between fasting and seizures. Rekindled interest in metabolic and dietary therapies for brain disorders complements new insight into their mechanisms and broader implications. Here we describe the emerging relationship between a KD and adenosine as a way to reset brain metabolism and neuronal activity and disrupt a cycle of dysfunction. We also provide an overview of the effects of a KD on cognition and recent data on the effects of a KD on pain, and explore the relative time course quantified among hallmark metabolic changes, altered neuron function and altered animal behavior assessed after diet administration. We predict continued applications of metabolic therapies in treating dysfunction including and beyond the nervous system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Astrocytic Purinergic Signaling Coordinates Synaptic Networks
Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H., Moss, S. J., McCarthy, K., & Haydon, P. G. (2005) · Science · doi:10.1126/science.1116916 · Cited by 1,280 · cited 1×
“…et al., 1993; Costenla et al., 1999; de Mendonca and Ribeiro, 2000; Fujii et al., 2000a,b; Tabata et al., 2001; Zhang et al., 2004; Rex et al., 2005; but see Pascual et al., 2005) and, when applied after induction, promotes reversal of existing LTP (Huang et al., 1999; Fujii et al., 2000a).”
BackgroundAnticonvulsant Mechanisms of the Ketogenic Diet
Bough, K. J., & Rho, J. M. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.00915.x · Cited by 523
D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease
Tieu, K., Perier, C., Caspersen, C., Teismann, P., Wu, D.-C., Yan, S.-D., Naini, A., Vila, M., Jackson-Lewis, V., Ramasamy, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318797 · Cited by 497 · cited 1×
“Direct application of ketones is also beneficial in models of Parkinson’s disease (Kashiwaya et al., 2000; Tieu et al., 2003) and Alzheimer’s disease (Kashiwaya et al., 2000).”
BackgroundWestman, E. C., Yancy, W. S., Mavropoulos, J. C., Marquart, M., & McDuffie, J. R. (2008) · Nutrition & Metabolism · doi:10.1186/1743-7075-5-36 · Cited by 475
Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy
Lefevre, F., & Aronson, N. (2000) · Pediatrics · doi:10.1542/peds.105.4.e46 · Cited by 331 · cited 1×
“Soon after beginning a KD, subjects often complain of lethargy (Vining et al., 1998; Lefevre and Aronson, 2000); in children, intolerable drowsiness is a reported side-effect that sometimes leads to cessation of KD treatment (Neal et al., 2008a).”
BackgroundRapid Broad-Spectrum Analgesia through Activation of Peroxisome Proliferator-Activated Receptor-α
LoVerme, J., Russo, R., La Rana, G., Fu, J., Farthing, J., Mattace-Raso, G., Meli, R., Hohmann, A., Calignano, A., & Piomelli, D. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111385 · Cited by 316
Johannessen Landmark, C. (2008) · CNS Drugs · doi:10.2165/00023210-200822010-00003 · Cited by 316 · cited 1×
“Second, anticonvulsant drugs such as gabapentin, felbamate, and valproate are useful in treating pain, particularly neuropathic pain and migraine (Johannessen Landmark, 2008).”
BackgroundMinireview: Inflammation and Obesity Pathogenesis: The Hypothalamus Heats Up
Thaler, J. P., & Schwartz, M. W. (2010) · Endocrinology · doi:10.1210/en.2010-0336 · Cited by 313
A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease
Van der Auwera, I., Wera, S., Van Leuven, F., & Henderson, S. T. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-28 · Cited by 307
Long-term effects of a very low-carbohydrate diet and a low-fat diet on mood and cognitive function
Brinkworth, G. D. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.329 · Cited by 205 · cited 4×
“…task (but not two other tasks) at 1 week of diet treatment but found no impairments at later time points (Wing et al., 1995); two studies examining chronic KD treatments reported improved processing speed and working memory lasting up to 1 year (Halyburton et al., 2007; Brinkworth et al., 2009).”
BackgroundResultInfluential
Cited by
Intermittent metabolic switching, neuroplasticity and brain health
Mattson, M. P., Moehl, K., Ghena, N., Schmaedick, M., & Cheng, A. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.156 · Cited by 624
Xie, G., Zhou, Q., Qiu, C.-Z., Dai, W.-K., Wang, H.-P., Li, Y.-H., Liao, J.-X., Lu, X.-G., Lin, S.-F., Ye, J.-H., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i33.6164 · Cited by 291
Saslow, L. R., Mason, A. E., Kim, S., Goldman, V., Ploutz-Snyder, R., Bayandorian, H., Daubenmier, J., Hecht, F. M., & Moskowitz, J. T. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.5806 · Cited by 265
Saslow, L. R., Daubenmier, J. J., Moskowitz, J. T., Kim, S., Murphy, E. J., Phinney, S. D., Ploutz-Snyder, R., Goldman, V., Cox, R. M., Mason, A. E., et al. (2017) · Nutrition & Diabetes · doi:10.1038/s41387-017-0006-9 · Cited by 241
Treatment of central sensitization in patients with ‘unexplained’chronic pain: An update
Nijs, J., Malfliet, A., Ickmans, K., Baert, I., & Meeus, M. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.925446 · Cited by 195
“It is indeed known that metabolism influences brain activity [92].”
Background
Metadata
- Authors
- Ruskin, D. N., & Masino, S. A.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 6
- Pages
- 33-33
- ISSN
- 1662-453X (ISSN-L)
- 1662-4548
- OpenAlex
- W2118550312
- Cited by
- 67
- References
- 14
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Nervous System and Metabolic Dysregulation: Emerging Evidence Converges on Ketogenic Diet Therapy. https://app.cochat.ai/papers/10.3389/fnins.2012.00033
- The paper
- Ruskin, D. N., & Masino, S. A. (2012). The Nervous System and Metabolic Dysregulation: Emerging Evidence Converges on Ketogenic Diet Therapy. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2012.00033
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.